共 105 条
[1]
Przemioslo RT(1995)Pathogenesis of Crohn’s disease Q J Med 88 525-527
[2]
Ciclitira PJ(2004)Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD Gastrointest Endosc 60 505-512
[3]
Daperno M(1999)Surgical therapy for ulcerative colitis and Crohn’s disease Gastroenterol Clin North Am 28 371-390
[4]
D’Haens G(1998)Early lesions of recurrent Crohn’s disease caused by infusion of intestinal excluded ileum Gastroenterology 114 262-267
[5]
Van Assche G(1990)Predictability of the postoperative course of Crohn’s disease Gastroenterology 99 956-963
[6]
Becker JM(2005)Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis J Manag Care Pharm 11 383-393
[7]
D’Haens GR(2005)Sargramostim in Crohn’s disease study group. Sargramostim for active Crohn’s disease N Engl J Med 352 2193-2201
[8]
Geboes K(2005)Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: a randomized, double-blind, placebo-controlled trial Gastroenterology 128 856-861
[9]
Peeters M(2001)MR enteroclysis imaging of Crohn disease Radiographics 21 161-172
[10]
Baert F(2006)Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis Eur Radiol 16 2817-2827